Knee osteoarthritis, symptomatic knee osteoarthritis, degenerative joint disease, chronic knee pain, physical therapy
Conditions
Interventions
The HILT group was delivered with an Nd: YAG device (BTL-6000, YAG HT, UK
1064 nm). Participants lay supine with the target knee flexed 30 degree on a pillow. Treatment comprised two sequential phases: Analgesic phase: power 10 W, dosage 12 J/cm2, frequency 25 Hz, area 25 c
Experimental Device,Active Comparator Device
HILT group,US group
Sponsors
CHANTANEE NINLERD
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with knee osteoarthritis according to American College of Rheumatology classification criteria had pain in the knee and at least three of the following: Over 50 years old, morning stiffness less than 30 minutes, with crepitus sound, with bony tenderness, bony enlargement and nonpalpable warmth, 2. Kallgren-Lawrence radiographic grade II-III, 3. body mass index less than 35, 4. Had pain around the knee joint at least 3 months, 5. Had pain score more than 3, 6. ability to provide informed consent and complete questionnaires.
Exclusion criteria
Exclusion criteria: 1.Had metal implants or an accident at affected side, 2. Had received physical therapy or other knee related treatment within 3 months, 3. Corticosteroids injection within 6 months, 4.BMI more than 35 , 5. Arthritis disease such as rheumatoid arthritis, gout, 6.Neuromuscular disease such as amyotrophic lateral sclerosis, muscular dystrophy, myasthenia gravis, spinal muscular atrophy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WOMAC total score baseline before the first treatment session (T0), at 6 sessions (T1), immediately after finishing treatment session (T2) and 12 weeks after the last treatment session (T3). Modified Thai version of the Western Ontario and McMaster WOMAC Osteoarthritis Index for Knee Osteoarthritis (WOMACVA 3.01, Thai-validated) | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain baseline before the first treatment session (T0), at 6 sessions (T1), immediately after finishing treatment session (T2) and 12 weeks after the last treatment session (T3). Visual Analog Scale (VAS),Oxford Knee Score baseline before the first treatment session (T0), at 6 sessions (T1), immediately after finishing treatment session (T2) and 12 weeks after the last treatment session (T3). Oxford Knee Questionnaire, validated Thai version,KOOS baseline before the first treatment session (T0), at 6 sessions (T1), immediately after finishing treatment session (T2) and 12 weeks after the last treatment session (T3). Thai version of KOOS,EQ-VAS baseline before the first treatment session (T0), at 6 sessions (T1), immediately after finishing treatment session (T2) and 12 weeks after the last treatment session (T3). EQ-5D-5L Questionnaire, Thai version,EQ-Utility baseline before the first treatment session (T0), at 6 sessions (T1), immediately after finishing treatment session (T2) and 12 weeks after the last treatment session (T3). EQ-5D-5L Questionnaire, Thai version,WOMAC subscale compare within group between T0 and T3 , T2 and T3 Modified Thai version of the Western Ontario and McMaster WOMAC Osteoarthritis Index for Knee Osteoarthritis (WOMACVA 3.01, Thai-validated | — |
Countries
Thailand
Contacts
Public ContactCHANTANEE NINLERD
Physical therapy branch, Department of Orthopaedic surgery, Faculty of Medicine Siriraj hospital, mahidol university
Outcome results
None listed